Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry

American Journal of Surgical Pathology

Volumn 22, Issue 10, 1998, Pages 1184-1191

  Rüdiger, Thomas ^a   Ott, German ^a   Ott, Maria Michaela ^a   Müller Deubert, Sigrid Maria ^a   Müller Hermelink, Hans Konrad ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Diagnosis; Differential diagnosis; Hodgkin's lymphoma; Immunohistochemistry; Paraffin; Paragranuloma; Pathology; T cell rich B cell lymphoma

Indexed keywords

CD15 ANTIGEN; CD20 ANTIGEN; CD30 ANTIGEN; CD57 ANTIGEN; PARAFFIN; VIMENTIN;

ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DIFFERENTIAL DIAGNOSIS; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MAJOR CLINICAL STUDY; NODULAR LYMPHOMATOSIS; T LYMPHOCYTE;

ANTIGENS, CD20; ANTIGENS, CD57; DIAGNOSIS, DIFFERENTIAL; HODGKIN DISEASE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOMA, B-CELL; MEMBRANE PROTEINS; PARAFFIN EMBEDDING; POLY(A)-BINDING PROTEINS; PROTEINS; RETROSPECTIVE STUDIES; RNA-BINDING PROTEINS; T-LYMPHOCYTES; VIMENTIN;

EID: 0141786164     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199810000-00003     Document Type: Article

References (31)

1. Acaba L, Santiago N, Velez Garcia E. T-cell-rich B-cell lymphoma masquerading as Hodgkin disease: excellent outcome to inadequate therapy. Bol Asoc Med P R 1996;88:32-4.
2. Alavaikko MJ, Blanco G, Aine R, et al. Follicular dendritic cells have prognostic relevance in Hodgkin's disease. Am J Clin Pathol 1994;101:761-7.
3. Baddoura FK, Chan WC, Masih AS, Mitchell D, Sun NC, Weisenburger DD. T-cell-rich B-cell lymphoma. A clinicopathologic study of eight cases. Am J Clin Pathol 1995;103:65-75.
4. Camilleri Broet S, Molina T, Audouin J, Tourneau AL, Diebold J. Morphological variability of tumour cells in T-cell-rich B-cell lymphoma. A histopathological study of 14 cases. Virchows Arch 1996;429:243-8.
5. Chittal SM, Brousset P, Voigt JJ, Delsol G. Large B-cell lymphoma rich in T cells and simulating Hodgkin's disease. Histopathology 1991;19:211-20.
6. Delabie J, Vandenberghe E, Kennes C, et al. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype. Am J Surg Pathol 1992;16:37-48.
7. Diehl V, Sieber M, Ruffer U, et al. BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study Group. Ann Oncol 1997;8: 143-8.
8. Farhi DC. T-cell-rich B-cell lymphoma. Reflections on changes in hematopathology. Am J Clin Pathol 1995;103:4-5.
9. Greer JP, Macon WR, Lamar RE, et al. T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patients. J Clin Oncol 1995;13:1742-50.
10. Harris NL, Jaffe ES, Stein H, et al. A Revised European-American Classification of Lymphoid Neoplasms: A Proposal From the International Lymphoma Study Group. Blood 1994;84:1361-92.
11. Kamel OW, Gelb AB, Shibuya RB, Warnke RA. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma. Am J Pathol 1993; 142:541-6.
12. Khan SM, Cottrell BJ, Millward Sadler GH, Wright DH. T-cell-rich B-cell lymphoma presenting as liver disease. Histopathology 1993;23:217-24.
13. Kuppers R, Rajewsky K, Zhao M, Simons G, Laumann R, Fischer R, Hansmann ML. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA 1994;91: 10962-6.
14. Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin's disease. Cancer Res 1966;26:1063-81.
15. Macon WR, Williams ME, Greer JP, Stein RS, Collins RD, Cousar JB. T-cell-rich B-cell lymphomas. A clinicopathologic study of 19 cases. Am J Surg Pathol 1992;16:351-63.
16. Marafioti T, Hummel M, Anagnostopoulos I, et al. Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med 1997;337:453-8.
17. Mason DY, Banks PM, Chan J, et al. Nodular lymphocyte predominance Hodgkin's disease. A distinct clinicopathological entity. Am J Surg Pathol 1994;18:526-30.
18. McCarthy KP, Sloane JP, Wiedemann LM. Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens. J Clin Pathol 1990;45:429-32.
19. Ng CS, Chan JKC, Hui PK, Lau WH. Large B-cell lymphomas with a high content of reactive T cells. Hum Pathol 1989;20:1145-54.
20. Osborne BM, Butler JJ, Pugh WC. The value of immunophenotyping on paraffin sections in the identification of T-cell rich B-cell large-cell lymphomas: lineage confirmed by JH rearrangement. Am J Surg Pathol 1990;14:933-8.
21. Oudejans JJ, Jiwa NM, Kummer JA, et al. Activated cytotoxic T cells as prognostic marker in Hodgkin's disease. Blood 1997;89: 1376-82.
22. Ramsay AD, Smith WJ, Isaacson PG. T-cell-rich B-cell lymphoma. Am J Surg Pathol 1988;12:433-43.
23. Rodriguez J, Pugh WC, Cabanillas F. T-cell-rich B-cell lymphoma. Blood 1993;82:1586-9.
24. Schmidt U, Herbst J, Metz KA, Leder LD. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining. J Pathol 1996;179:138-44.
25. Sextro M, Diehl V, Franklin J, Hansmann ML, Anagnostopoulos I, Marafioti T, Stein H. Lymphocyte predominant Hodgkin's disease - a workshop report. European Task Force on Lymphoma. Ann Oncol 1996;7(suppl 4):61-5.
26. Siebert JD, Stuckey JH, Kurtin PJ, Banks PM. Extranodal lymphocyte predominance Hodgkin's disease. Clinical and pathologic features. Am J Clin Pathol 1995;103:485-91.
27. Tajima K, Fukase N, Shiono T, Katagiri T, Mito S. An autopsied case of T-cell rich B-cell lymphoma with general involvement. Intern Med 1995;34:243-6.
28. von Wasielewski R, Mengel M, Fischer R, et al. Classical Hodgkin's disease clinical impact of the immunophenotype. Am J Pathol 1997;151:1123-30.
29. von Wasielewski R, Werner M, Fischer R, et al. Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group. Am J Pathol 1997;150:793-803.
30. Warnke RA, Weiss LM, Chan JKC, Cleary ML, Dorfman RF. Tumors of the Lymph Nodes and Spleen, vol. , fascicle 14. Washington, DC: Armed Forces Institute of Pathology; 1995.
31. Zukerberg LR, Collins AB, Ferry JA, Harris NL. Coexpression of CD15 and CD20 by Reed-Sternberg Cells in Hodgkin's Disease. Am J Pathol 1991;139:475-83.